NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/08/2022
Voltar para busca
Dado oficial do USPTO
VELVIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VELVIO
ST13
US500000088637718Classe
5, 10, 42, 44
Pedido
88637718
Registro
6805773
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
02/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
01/10/2019
Data de registro
02/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/08/2022
Última transação
02/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
16
Localização do titular
Regensburg, DE
Examinador
WERT, KARL
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Velvio GmbH
Representantes
David A Lowe LOWE GRAHAM JONES
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinesmedicines for the treatment of bone diseases; Medicines for the treatment of immune system related diseases and disorders; Medicines for the prevention of autoimmune diseases; Medicines for treating rheumatological diseases; Medicines for the treatment of cancer; Medicines for activating cellular function; Medicines for treating malignant tumors; Medicines for immunity adjustment; Medicines for regulating the immune system; Medicines for the treatment of autoimmune diseases; Medicines for use in chemotherapy; Medicines for use in oncology; Medicines and pharmaceutical substances for the treatment of cancer; Medicines and pharmaceutical substances for the prevention of cancer; Medicines and pharmaceutical substances for use in oncology; Medicines for the treatment of Parkinson's disease; Medicines for the treatment of central nervous system diseases; Medicines for the treatment of multiple sclerosis; Medicines for peripheral nervous system; Medicines for the treatment of epilepsy; Medicines for treating sensory organ disorders; Medicines for the prevention of disorders of the immune system; Medicines for use in tissue transplantation; Medicines for use in organ transplantation; Medicines for the prevention of disorders of the nervous system; Medicines for the prevention of diseases of the nervous system; Diagnostic preparations for medical purposes and diagnostic materialsdiagnostic agents for medical purposesdiagnostic substances for medical purposes; Biochemical preparations for medical usefor treatment of cancer; Chemical preparations for medical purposesfor treatment of cancer; Cardiovascular agents for medical purposes; Medicinal healthcare preparations for treatment of cancer; Medical preparations for treatment of cancer; Cellular function activating agents for medical purposes; Nucleic acid sequences for medical purposes; Organotherapeutics; Reagents for medical use; Stem cells for medical use; Pre- filled syringes for medical purposesfilled with medicine for treatment of cancer; Anti-cancer drugsAnti-cancer preparationsPharmaceutical products for the prevention and treatment of cancer; Medicines for intestinal disorders; Medicines for the treatment and prevention of lung disorders; Medicines for the treatment and prevention of liver disorders; Medicines for the treatment and prevention of kidney disorders; Medicines for the treatment and prevention of reproductive organ disorders; Medicines for the treatment and prevention of heart and heart valve disorders; Medicines for genetic reprogramming of cells and organs for prevention of intestinal disorders; Medicines for the treatment of the nervous system; Medicines for the treatment of brain and spinal cord trauma including paraplegia; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical usegenetically engineered biological preparations for the treatment of cancer; Chemico-pharmaceutical preparations for treatment of cancer; Chemicals for pharmaceutical usechemical reagents for pharmaceutical or medical purposes; Chemical preparations for pharmaceutical medical purposes for treatment of cancer; Chemical preparations for pharmaceutical purposesfor treatment of cancer; Anti-cancer preparations of chemical origin; Chemotherapeutics; Cardiovascular treatment preparations; Immunomodulators being a type of pharmaceutical preparation for the treatment of immune system related diseases and disorder; Immunoassay reagents for medical use; Immunostimulants; Antitumor drugsTumor suppressing agents; Nervinesfor treatment of nervous system; Tissue-regenerative pharmaceutical preparations; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for treating rheumatological diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for treating sensory organ disorders; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical preparations for use in organ transplantation; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Compounds for treating cancerDrug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for treating cancerBiometallic compounds being a component in pharmaceutical preparations for treating cancer; Central nervous system stimulants; Tumor suppressing agents; Ethical medicinal preparations for treatment of canceruse in dermatology; Cytostatics for medical purposes; Bacteriological preparations for medical use; Biological reagents for medical use; Diagnostic chemical reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis for medical purposes; Pharmaceuticals for the therapy and prophylaxis of neurodegenerative diseases; Pharmaceuticals for the therapy and prophylaxis of Morbus AlzheimerMorbus ParkinsonMorbus Huntingtonamyotrophic lateral sclerosis (ALS)acquired immunodeficiency syndrome AIDS dementiaRetinitis pigmentosaspinal muscular atrophycerebellar degenerationfragile X-associated tremor/ataxia syndrome (FXTAS)progressive supranuclear palsy (PSP)striatonigral degeneration (SND)Shy-Drager syndrome (SDS); Pharmaceuticals for the therapy and prophylaxis of multiple system atrophy (MSA)parkinsonian type (MSA-P) or formerly olivopontocerebellar atrophy (OPCA)all of the entities of hydrocephalus including normal pressure hydrocephalusparaplegiacondition after hypoxia and resuscitationcognitive deficiencies after inflammatory or infectious CNS disorders; Pharmaceuticals for the therapy and prophylaxis of forms of fibrotic tissue transformation including presbycusispresbyopiaglaucomaforms of pulmonary fibrosisincluding Idiopathic pulmonary fibrosis (IPF)liver cirrhosiskidney diseasesgynecological disorderskeloid formations after trauma; Chemical and biological productsdiagnostic preparations for medical purposes for diagnosing neurodegenerative diseasespulmonary diseasesliver cirrhosisoncological diseases; Diagnostic preparationsin particulardiagnostics preparations for medical purposes and for diagnosing central nervous system (CNS) disordersforms of fibrotic tissue transformationspulmonary diseasesliver cirrhosiskidney diseasesgynecological disordersoncological diseases
Classe 10
Medical apparatus for the treatment of cancer; Medical apparatus for the treatment of lung ailments; Medical apparatus for the treatment of disease of the prostate; Medical apparatus for taking body fluid samples; Apparatus for medical cell sampling for medical use in testing cancer levels; Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus for use in the diagnosis of metabolic disorders; Medical apparatus for administering intravenous solutions for use in general surgery; Applicators for medicationsmedical apparatus for introducing pharmaceutical preparations into the human body; Medical applicators for introducing pharmaceutical preparations into the human body; Automatic medical apparatus for dosing humans with pharmaceutical preparationsmedical drugs by injection; Metering pumps for delivering drugs in measured quantitiesfor medical use and sold empty; Electronic nerve stimulators for medical use; Electronic muscle stimulators for medical use; Electrophoresis apparatus for medical use; Medical apparatus for tumor diagnosis; Apparatus for administering pharmaceuticalsinfusion and injection medical devices for administering pharmaceutical drugsmedical tubing for administering pharmaceutical drugs; Infusion apparatusinfusion sets for therapeutic purposes; InhalersInhalers for therapeutic use and sold emptyOxygen inhalators for medical use and sold empty; Inhalers for the evaporation of para-medical substances for medical purposes; Inhalers for medical use; Injection device for pharmaceuticals; Medication injectorsmedication injection instruments with needlesmedical apparatus in the nature of an injection device for administering drugs; Medical imaging apparatus for neurographic purposes; Medical apparatus for introducing pharmaceutical preparations; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Pumps implantable drug delivery pumps for medical use in delivering pharmaceuticals from containers; Specimen samplers for medical usemedical apparatus for taking blood samplesSample preparation device for medical diagnostic uses; Medical syringes; Hypodermic needles for injection; Hypodermic syringes for use in administering injection substances; Portable nebulisers for medical purposes; Nebulizers for medical use; Medical apparatusSurgical apparatus and instruments for medical use
Classe 42
Science and technology servicesScientific researchResearch and development of technology in the field of pharmaceuticals; Medical and pharmacological research services; Consultancy relating to research in the field of pharmacogenetics; Consultancy relating to pharmaceutical research and development; Consultancy relating to scientificproduct research and development in the field of therapeutics; Consultancy pertaining to pharmacology; Consultancy in the field of pharmaceutical research; Consultancy relating to laboratory testing; Provision of information and data in the nature of scientific research information relating to medical research and development; Providing scientific researchproduct research information about the results of clinical trials for pharmaceutical products; Pharmaceutical product evaluation; Biological researchclinical research in the field of cancer treatmentradiologychemotherapycoronary artery bypass surgery and medical research; Biomedical research services; Medical research laboratory services; Medical laboratory services; Services in the nature of product testing for assessing the efficiency of pharmaceuticals; Testing of pharmaceuticals; Conducting clinical trials for pharmaceutical products performed for others; Analysis of human tissues performed for medical research purposes; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research in the field of cancer treatmentradiologychemotherapycoronary artery bypass surgery; Scientific research in the nature of conduction clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical drug development services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and development; Scientific research for medical purposes in the field of cancerforms of fibrotic tissue transformationsnervous system disordersforms of pulmonary fibrosis including idiopathic pulmonary fibrosis (IPF)liver cirrhosisbrain and spinal cord trauma diseases including paraplegia; Scientific investigations for medical purposes; Growing of tissue performed as part of scientific research servicesmedical research services; Contract research and contract development of pharmaceuticals; Contract research and contract development of pharmaceuticalsmedicines for the therapy of neurodegenerative diseases scientificproduct research and development in the medicalpharmaceuticalpharmacologicalbiochemicalgenetic engineering and medical technology fieldsfor others; Contract clinical tests and clinical studiesscientific research in the nature of conducting clinical trials for others; Providing scientific expertisein particularproviding scientific research and development servicesscientific research consulting in the field of pharmaceuticals for scientific projectsclinical trials and clinical studies; Consultancy and Information services relating to product developmentproduct research of medical product; Advisory services relating to product developmentproduct research of medical apparatus and instruments; Consultancy and information services relating to product developmentproduct research of pharmaceutical products; Consultancy and information services relating to product developmentproduct research of biopharmaceutical products
Classe 44
Human healthcare services; Medical services; Health advice and information services; Professional consultancy relating to health care; Advisory services relating to health; Laboratory analysis services relating to the treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and healthcare services; Stem cell storage servicesisolationcollectionbanking of umbilical cord tissue perivascular stem cells; Advisory services relating to the treatment of degenerative diseases; Providing news and information in the field of medicine; Advisory services relating to medical diagnosis serviceshealthcare treatments services relating to degenerative diseases; Consultancy and information services relating to medical productsconsultancy and information services relating to rental of medical equipmentconsultancy and information services relating to medical services involving medical products; Advisory services relating to medical apparatus and instrumentsconsultancy and information services relating to medical services involving medical apparatuses and instruments; DNA screening for medical purposes; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical analysis services for the diagnosis of cancer; Medical screening; Medical services featuring RNA or DNA analysis for cancer diagnosis and prognosis; Providing cancer screening services; Genetic testing for medical purposes; Individual medical counseling services provided to patients; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services relating to the treatment of persons; Medical analysis for diagnostic and treatment purposes provided by medical laboratories; Medical analysis for the diagnosis and treatment of persons; Medical diagnostic testingmonitoring and reporting services; Medical services in the field of oncology; Medical services relating to the removaltreatment and processing of bone marrow; Medical services relating to the removaltreatment and processing of stem cells; Medical services relating to the removaltreatment and processing of human blood; Medical services relating to the removaltreatment and processing of human cells; Medical and health assessment services relating to DNAgenetics and genetic testing; Medical services for the diagnosis of conditions of the human body; Medical servicesanalysis of human tissues for medical treatment; Medical servicesanalysis of human serum for medical treatment; Pharmaceutical servicespharmaceutical advicedispensing of pharmaceuticals; Provision of information relating to medicine; Provision of pharmaceutical informationproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; Pharmacy advicepharmaceutical advise; Consultancy and information services in the field of pharmaceutical advicehealthcare information relating to pharmaceutical products; Consultancy and information services in the field of pharmaceutical advicehealthcare information relating to biopharmaceutical products; Preparation and dispensing of medications; Providing information relating to the preparation and dispensing of medications
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
23/06/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
29/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/12/2021
PUBO
PUBLISHED FOR OPPOSITION
14/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/11/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
22/10/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/10/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
22/10/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/09/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/08/2021
GNSL
LETTER OF SUSPENSION E-MAILED
26/08/2021
CNSL
SUSPENSION LETTER WRITTEN
26/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/08/2021
ALIE
ASSIGNED TO LIE
17/08/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/08/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/02/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/08/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/08/2020
CNSL
SUSPENSION LETTER WRITTEN
06/08/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
23/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
23/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/07/2020
DOCK
ASSIGNED TO EXAMINER
26/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/01/2020
GNRT
NON-FINAL ACTION E-MAILED
06/01/2020
CNRT
NON-FINAL ACTION WRITTEN
06/01/2020
DOCK
ASSIGNED TO EXAMINER
06/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2019
NWAP
NEW APPLICATION ENTERED
04/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VELVIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.